We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Entergy Corporation (ETR) Misses on Q1 Earnings Estimates
Read MoreHide Full Article
New Orleans, LA based Entergy Corporation (ETR - Free Report) is primarily engaged in electric power production and retail distribution of power. Entergy's disciplined investments in growth projects are expected to be the major drivers for earnings over the long haul. Entergy plans to invest $11.2 billion in the 2018–2020 time frame, with the major share going to its generation and transmission business.
However, the company depends upon rate relief at regular intervals and any adverse decision can materially impact the company’s earnings.
Surprise History
Coming to the earnings surprise, Entergy has surpassed the Zacks Consensus Estimate in three of the last four quarters, resulting in a positive average surprise of 60.21%.
Stock Price: It would be interesting to see how the market reacts to the earnings release during the trading session today.
Check back for our full write up on this ETR earnings report later!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
Entergy Corporation (ETR) Misses on Q1 Earnings Estimates
New Orleans, LA based Entergy Corporation (ETR - Free Report) is primarily engaged in electric power production and retail distribution of power. Entergy's disciplined investments in growth projects are expected to be the major drivers for earnings over the long haul. Entergy plans to invest $11.2 billion in the 2018–2020 time frame, with the major share going to its generation and transmission business.
However, the company depends upon rate relief at regular intervals and any adverse decision can materially impact the company’s earnings.
Surprise History
Coming to the earnings surprise, Entergy has surpassed the Zacks Consensus Estimate in three of the last four quarters, resulting in a positive average surprise of 60.21%.
Zacks Rank: Currently, Entergy sports a Zacks Rank #1 (Strong Buy) but that could change following its first-quarter 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We have highlighted some of the key details from the just-released announcement below:
Earnings: Entergy’s first-quarter adjusted earnings per share came in at $1.16, which missed the Zacks Consensus Estimate of $1.31 by 11.5%.
Key Stats: The company registered a 0.2% year over year improvement in total retail customer count in first-quarter 2018.
Entergy Corporation Price and EPS Surprise
Entergy Corporation Price and EPS Surprise | Entergy Corporation Quote
Stock Price: It would be interesting to see how the market reacts to the earnings release during the trading session today.
Check back for our full write up on this ETR earnings report later!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>